PTBP1 α3-helix derived peptide P1 (TFA)

PTBP1 α3-helix derived peptide P1 (TFA)

• UNSPSC Description: PTBP1α3-helix derived peptide P1 is a polypeptide that inhibits RNA binding[1].
• Target Antigen: Others
• Type: Peptides
• Related Pathways: Others
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/ptbp1-α3-helix-derived-peptide-p1-tfa.html
• Purity: 98.88
• Smiles: O=C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(N)=O)NC(C)=O.xO=C(O)C(F)(F)F
• Molecular Weight: 1551.71 (free base)
• References & Citations: [1]Schmeing S, et al. Rationally designed stapled peptides allosterically inhibit PTBP1-RNA-binding. Chem Sci. 2023 Jul 13;14(31):8269-8278.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
• Clinical Information: No Development Reported